Cytotoxic T lymphocytes (CTL) specific for human immunodeficiency virus type 1 (HIV-1) are thought to play an important role in controlling HIV-1 infection. HIV-1-specific CTL are readily demonstrated in unstimulated peripheral blood mononuclear cells (PBMC) of HIV-infected adults but less frequently in PBMC from vertically infected children. HIV-1-specific CTL lines were derived from a long-term survivor of vertical HIV-1 infection using PBMC stimulated with a CD3-specific monoclonal antibody and interleukin-2; these lines had Gag- or reverse transcriptase (RT)-specific cytotoxicity. Cytotoxicity was restricted by major histocompatibility complex class I antigen and blocked by antibody to the T cell receptor complex. Fluorescence-activated cell sorting analysis demonstrated their phenotype to be CD3+CD4-CD8+. Unstimulated PBMC from this patient had no detectable HIV-1-specific cytotoxicity when tested against autologous HIV-1 envelope-, Gag-, or RT-expressing target cells. Thus, this child with vertically acquired HIV-1 infection likely has HIV-1-specific CTL precursors despite the absence of circulating, activated HIV-1-specific CTL.
[1]
R. Koup,et al.
Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
,
1991,
The Journal of pediatrics.
[2]
B. Walker,et al.
Cytotoxic T lymphocytes against HIV.
,
1990,
AIDS.
[3]
D. Watkins,et al.
A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
,
1989,
Disease markers.
[4]
J. Sissons,et al.
Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity
,
1988,
European journal of immunology.
[5]
B. Walker,et al.
HIV-specific cytotoxic T lymphocytes in seropositive individuals
,
1987,
Nature.
[6]
A. McMichael,et al.
Cytotoxic T-cell immunity to influenza.
,
1983,
The New England journal of medicine.